SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,647.49 -476.34
( -0.65%)

Global Indices

Nasdaq

52,230.09 -658.89
(-1.25%)

Dow Jones

7,644.13 -40.30
(-0.52%)

Hang Seng

62,584.98 -322.86
(-0.51%)

Nikkei 225

10,670.63 -54.40
(-0.51%)

Forex

USD-INR

94.61 0.10
(0.11%)

EUR-INR

106.18 0.08
(0.07%)

GBP-INR

126.70 0.19
(0.15%)

JPY-INR

0.60 0.00
(0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524742

INE475E01026

269.7614245

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CAPLIPOINT

40.24

16890.94

EPS(TTM)

Face Value()

Div & Yield %

55.22

0.36

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	738.33	752.41	625.09	528.61	528.06	482.68
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	738.33	752.41	625.09	528.61	528.06	482.68
Other Income	195.37	134.59	105.84	99.00	56.55	18.62
Stock Adjustments	12.37	-24.36	43.68	1.67	9.00	0.57
Total Income	946.07	862.64	774.61	629.28	593.61	501.87
EXPENDITURE :
Raw Materials	241.33	213.81	248.90	199.73	213.65	195.40
Power & Fuel Cost	13.64	14.11	15.43	9.89	9.54	6.36
Employee Cost	47.72	52.13	38.11	36.68	30.47	26.59
Other Manufacturing Expenses	27.05	24.00	25.43	13.73	10.81	7.75
Selling & Administrative Expenses	65.81	75.50	40.75	40.30	43.51	28.12
Miscellaneous Expenses	17.37	16.53	13.07	10.03	9.46	5.10
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	412.92	396.08	381.69	310.36	317.44	269.32
Operating Profit	533.15	466.56	392.92	318.92	276.17	232.55
Interest	0.20	0.12	0.10	0.12	0.09	0.17
Gross Profit	532.95	466.44	392.82	318.80	276.08	232.38
Depreciation	25.43	24.77	27.08	25.65	25.77	22.44
Profit Before Tax	507.52	441.67	365.74	293.15	250.31	209.94
Tax	109.49	102.90	86.12	66.58	61.62	54.88
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	1.45	-0.72	-4.09	-7.69	0.82	-1.17
Reported Net Profit	396.58	339.49	283.71	234.26	187.87	156.23
Extraordinary Items	13.29	-0.33	1.19	1.17	0.75	4.67
Adjusted Net Profit	383.29	339.82	282.52	233.09	187.12	151.56
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	1634.99	1333.49	1083.95	880.01	714.84	561.64
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	45.61	37.99	34.17	30.32	22.70	3.03
P & L Balance carried down	1985.96	1634.99	1333.49	1083.95	880.01	714.84
Dividend	22.81	18.99	15.19	15.16	11.35	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	400.00	300.00	250.00	225.00	200.00	150.00
Dividend Per Share(Rs)	8.00	6.00	5.00	4.50	4.00	3.00
Earnings Per Share-Unit Curr	52.18	44.67	37.35	30.86	24.78	20.65
Earnings Per Share(Adj)-Unit Curr	52.18	44.67	37.35	30.86	24.78	20.65
Book Value-Unit Curr	269.80	223.81	183.03	150.19	122.78	100.29
Book Value(Adj)-Unit Curr	269.80	223.81	183.03	150.19	122.78	100.29

72,647.49 -476.34 ( -0.65%)

52,230.09 -658.89 (-1.25%)

7,644.13 -40.30 (-0.52%)

62,584.98 -322.86 (-0.51%)

10,670.63 -54.40 (-0.51%)

94.61 0.10 (0.11%)

106.18 0.08 (0.07%)

126.70 0.19 (0.15%)

0.60 0.00 (0.70%)